UK markets close in 1 hour 27 minutes

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
217.83-1.09 (-0.50%)
As of 09:53AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
1,166,600
1,161,100
3,046,900
1,556,100
4,000,600
Depreciation & amortisation
530,000
494,800
518,400
487,700
457,200
Deferred income taxes
-201,400
-305,800
-168,600
-426,800
149,000
Stock-based compensation
261,400
264,200
254,100
238,600
198,300
Change in working capital
-693,300
-648,700
-890,300
-145,500
-187,200
Accounts receivable
27,800
61,300
-203,400
324,800
2,800
Inventory
-236,500
-130,900
-320,200
-462,400
-316,300
Other working capital
1,284,400
1,235,800
1,141,100
3,345,000
3,678,000
Other non-cash items
352,300
304,100
335,300
337,100
119,900
Net cash provided by operating activities
1,645,100
1,547,200
1,384,300
3,639,900
4,229,800
Cash flows from investing activities
Investments in property, plant and equipment
-360,700
-311,400
-243,200
-294,900
-551,800
Acquisitions, net
-
-6,926,100
0
0
-1,006,500
Purchases of investments
-3,819,500
-5,140,700
-3,448,500
-3,808,700
-6,397,700
Sales/maturities of investments
7,115,500
7,500,400
3,671,000
3,498,900
7,374,300
Other investing activities
-11,300
-11,300
24,400
12,900
-26,900
Net cash used for investing activities
-3,214,000
-4,101,000
1,576,600
-563,700
-608,600
Cash flows from financing activities
Debt repayment
-1,209,900
-809,900
-1,002,200
-170,000
-1,500,000
Common stock repurchased
-
0
-750,000
-1,800,000
-6,679,100
Other financing activities
-3,100
6,300
6,800
-115,500
-56,400
Net cash used provided by (used for) financing activities
-246,900
149,300
-1,747,300
-2,086,200
-5,272,700
Net change in cash
-1,815,800
-2,404,500
1,213,600
990,000
-1,651,500
Cash at beginning of period
2,898,200
3,419,300
2,261,400
1,331,200
2,913,700
Cash at end of period
-
1,049,900
3,419,300
2,261,400
1,331,200
Free cash flow
Operating cash flow
1,645,100
1,547,200
1,384,300
3,639,900
4,229,800
Capital expenditure
-360,700
-311,400
-243,200
-294,900
-551,800
Free cash flow
1,284,400
1,235,800
1,141,100
3,345,000
3,678,000